Search results for "pericarditis"

showing 10 items of 23 documents

IL-1 BLOCKADE IN PAEDIATRIC RECURRENT PERICARDITIS: A MULTICENTRIC RETROSPECTIVE STUDY OF THE ITALIAN COHORT

2019

Introduction: Acute pericarditis is an inflammatory condition causing the occurrence of pericardial effusion. In a third of patients, the disease is recurrent. First line treatment of idiopathic pericarditis consists in non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine; glucocorticoids represent the second line treatment in resistant or intolerant cases. A recent clinical trial has enlightened the effectiveness of anakinra in adults and paediatric patients with colchicine-resistant recurrent pericarditis. Objectives: To describe the clinical characteristics and response to treatment in a cohort of paediatric patients with recurrent pericarditis treated with IL inhibitors. Method…

Settore MED/38 - Pediatria Generale E SpecialisticaRecurrent pericarditis Anakinra Colchicine-resistence Canakinumab
researchProduct

Characteristics and Outcomes of Patients Hospitalized With Suspected Acute Coronary Syndrome in Whom the Diagnosis is not Confirmed

2018

Patients admitted with suspected acute coronary syndrome (ACS) in whom the diagnosis is not confirmed are poorly characterized. In a contemporary registry of consecutive patients hospitalized with suspected ACS as the primary diagnosis, we assessed characteristics on admission and in-hospital and 6-month mortality of patients discharged with other diagnoses and compared this subgroup with true ACS patients. Of 2557 patients included, 9.0% were discharged with a non-ACS diagnosis such as nonspecific chest pain, myopericarditis, stress cardiomyopathy, hemodynamic disturbances, heart failure, myocardial, pulmonary or valvular disease, or others. Compared with true ACS patients, those with othe…

MaleChest PainAcute coronary syndromemedicine.medical_specialtyCardiomyopathyHemodynamics030204 cardiovascular system & hematologyCoronary AngiographyChest painRisk AssessmentDiagnosis DifferentialElectrocardiography03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansHospital MortalityProspective StudiesRegistries030212 general & internal medicineAcute Coronary SyndromeMedical diagnosisAgedInpatientsbusiness.industryMortality rateMiddle AgedPrognosismedicine.diseaseHospitalizationSurvival RateSpainHeart failureCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesMyopericarditisThe American Journal of Cardiology
researchProduct

Acute myopericarditis in a young with autoimmune disorders

2012

MyopericarditisSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis

2021

The alarming onset of some cases of myocarditis and pericarditis following the administration of Pfizer–BioNTech and Moderna COVID-19 mRNA-based vaccines in adolescent males has recently been highlighted. All occurred after the second dose of the vaccine. Fortunately, none of patients were critically ill and each was discharged home. Owing to the possible link between these cases and vaccine administration, the US and European health regulators decided to continue to investigate the potential causal relationship between COVID-19 mRNA vaccines and myocarditis. In any case, none of the patients fulfilled the criteria for multi-system inflammatory syndrome or Kawasaki-like disease and there wa…

2019-20 coronavirus outbreakPediatricsmedicine.medical_specialtyOpinionMyocarditisCoronavirus disease 2019 (COVID-19)Kawasaki-like syndromeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Myocarditis; Pericarditis; Multi-system inflammatory disease; Kawasaki-like syndrome; SARS-CoV-2multi-system inflammatory diseaseDiseasepericarditisPediatricsRJ1-570PericarditisVaccine administrationvaccinemedicineCritically illbusiness.industrySARS-CoV-2Rmedicine.diseaseMedicinemyocarditisbusinessPediatric Reports
researchProduct

Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary fin…

2007

The aim of the present study was to evaluate the safety and efficacy of the combination of indomethacin and statin compared with indomethacin plus placebo in patients with a first episode of pericarditis. A total of 55 consecutive patients with acute pericarditis were randomized in a double-blind manner into two groups: group I (statin group) was treated with 150 mg of indomethacin plus 10 mg of rosuvastatin, and group 2 (placebo group) was treated with 150 mg of indomethacin plus placebo. Both groups received treatment up to the normalization of inflammation markers and for the following week. Clinical and laboratory assessments [white cell count, ESR (erythrocyte sedimentation rate) and C…

AdultMalemedicine.medical_specialtyIndomethacinPlaceboGastroenterologyElectrocardiographyPericarditisAcute pericarditisDouble-Blind MethodRecurrenceInternal medicineTroponin ImedicineHumansPericarditisRosuvastatinRosuvastatin CalciumPericarditis Colchicine Postpericardiotomy syndromeFirst episodeSulfonamidesmedicine.diagnostic_testbiologybusiness.industryAnti-Inflammatory Agents Non-SteroidalCardiovascular AgentsGeneral Medicinemedicine.diseaseSurgeryFluorobenzenesC-Reactive ProteinPyrimidinesTreatment OutcomeErythrocyte sedimentation rateAcute Diseasebiology.proteinDrug Therapy CombinationFemaleCreatine kinaseHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsbusinessFollow-Up Studiesmedicine.drugClinical Science
researchProduct

Myocarditis in Mediterranean spotted fever: a case report and a review of the literature

2016

Introduction: Mediterranean spotted fever (MSF) is a tick-borne acute febrile disease caused by Rickettsia conorii. Most cases follow a benign course, with a case fatality rate of 3–7 % among hospitalized patients. Complications are described mainly in adult patients and include hepatic, renal, neurological and cardiac impairment. Among cardiac complications, pericarditis, myocarditis and heart rhythm disorders are uncommon complications in MSF and only a few cases have been reported in the literature. Case Presentation: We describe a new case of acute myocarditis complicating MSF in an immunocompetent adult patient without risk factors for severe MSF. Conclusion: Myocarditis is an uncommon…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyPediatricsMyocarditisHeart rhythm disorders030106 microbiologyCase ReportDiseaseMediterraneanMicrobiology03 medical and health sciencesPericarditisZoonosis0302 clinical medicineCase fatality rateMedicinespotted030212 general & internal medicineconoriiIntensive care medicineBlood/Heart and Lymphaticsfeverbiologybusiness.industryMortality rateMediterranean; conorii; fever; myocarditis; rickettsia; spottedmedicine.diseasebiology.organism_classificationrickettsiaSpotted fevermyocarditimyocarditisbusinessRickettsia conoriiJMM Case Reports
researchProduct

Rare occurrence of Whipple Disease in a young female patient with a fatal outcome

2013

Abstract Whipple Disease is a rare chronic multi-systemic disease caused by the ubiquitous environmental Gram-positive bacterium Tropheryma whipplei . It can be fatal if untreated. Here we describe the fatal outcome in a 27-year-old Caucasian female patient with a three-month history of persistent fever, anemia, weight loss and diarrhea. The final resolution of the diagnostic process was only reached after the patient’s death thanks to autopsy. The case depicted is a classic Whipple Disease histologically characterized by digestive involvement based on positive periodic acid-Schiff (PAS) staining and immunohistochemical analysis for T. whipplei and systemic involvement (pericarditis, brain …

medicine.medical_specialtyPathologyForensic pathologyHealth (social science)AnemiaEpidemiologyAutopsyDiseasePathology and Forensic MedicineForensic pathologyTropheryma whippleiPericarditisSettore MED/43 - Medicina LegalemedicineFat embolismPost-mortem diagnosisbiologybusiness.industryWhipple DiseasePost-mortem diagnosibiology.organism_classificationmedicine.diseaseDermatologyImmunohistochemistryTropheryma whippleibusinessLawWhipple Disease
researchProduct

Irreversible acute renal failure and cholestatic hepatitis following therapy with indomethacin in an HIV-naive patient with pericarditis: a case repo…

2014

Settore MED/17 - Malattie Infettiveacute renal failure indomethacin HIV pericarditis
researchProduct

AN ATYPICAL CASE OF GIANT CELL ARTERITIS (HORTON'S DISEASE) ASSOCIATED WITH FACIAL SWELLING, CONFUSION, AND PERICARDITIS IN AN ELDERLY WOMAN

2010

Pathologymedicine.medical_specialtySystemic diseaseFacial swellingHeart diseaseVascular diseasebusiness.industryDiseasemedicine.diseasePericarditisGiant cell arteritismedicineGeriatrics and GerontologyVasculitisbusinessJournal of the American Geriatrics Society
researchProduct

0436: Diagnostic value of serial ultrasensible troponin I measurements for acute coronary syndrome identification in cardiac intensive care unit

2014

Introduction ACS diagnosis relies on the detection of an increase or a decrease in troponin levels (delta-TnI) that might be estimated as absolute (delta-TnI-abs) or relative value (delta-TnI-rel). The discriminative cut-off value of delta-TnI to identify ACS in patients admitted in ICU is a matter of debate. Methods We aimed to determine in a monocentric registry the cut-off value of delta-TnI to identify ACS among patients admitted in ICU with a suspicion of acute myocardial ischemia. All the patients had 2 measurements of ultrasensible cTnI (ADVIA Centaur Siemens®; 99th percentile: 0,04 μg/L). Patients were classified in 4 groups: 1) ACS (NSTEMI, UA), 2) Cardiac non coronary diseases (he…

Acute coronary syndromemedicine.medical_specialtybiologybusiness.industrymedicine.diseaseChest painmusculoskeletal systemTroponinPericarditisInternal medicineHeart failureTroponin ImedicineCoronary care unitbiology.proteinCardiologycardiovascular systemMyocardial infarctionmedicine.symptombusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct